Caifeng Yue

638 total citations
20 papers, 481 citations indexed

About

Caifeng Yue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Caifeng Yue has authored 20 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Caifeng Yue's work include MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Caifeng Yue is often cited by papers focused on MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Caifeng Yue collaborates with scholars based in China, Hong Kong and United Kingdom. Caifeng Yue's co-authors include Laisheng Li, Jierong Chen, Ziyue Li, Quentin Liu, Jie Xu, Min Yan, Qian Shi, Wei Cheng, Guohui Li and Xi Wang and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Caifeng Yue

18 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caifeng Yue China 9 305 150 113 84 66 20 481
Bei Sun China 13 283 0.9× 165 1.1× 184 1.6× 55 0.7× 69 1.0× 26 526
Pingsheng Fan China 12 354 1.2× 170 1.1× 130 1.2× 30 0.4× 45 0.7× 29 509
Maopeng Yang China 9 312 1.0× 226 1.5× 136 1.2× 25 0.3× 135 2.0× 16 486
Nader Hussein Lebanon 14 432 1.4× 223 1.5× 102 0.9× 29 0.3× 39 0.6× 24 599
Yingfeng Zhu China 10 338 1.1× 200 1.3× 74 0.7× 18 0.2× 47 0.7× 17 459
Junhao Mu China 14 333 1.1× 119 0.8× 71 0.6× 27 0.3× 33 0.5× 23 442
Rongkun Li China 15 420 1.4× 260 1.7× 111 1.0× 31 0.4× 27 0.4× 25 589
Judit López‐Luque Spain 8 179 0.6× 70 0.5× 95 0.8× 44 0.5× 37 0.6× 8 368
Shikai Zhu China 14 341 1.1× 211 1.4× 159 1.4× 33 0.4× 38 0.6× 30 546

Countries citing papers authored by Caifeng Yue

Since Specialization
Citations

This map shows the geographic impact of Caifeng Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caifeng Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caifeng Yue more than expected).

Fields of papers citing papers by Caifeng Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caifeng Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caifeng Yue. The network helps show where Caifeng Yue may publish in the future.

Co-authorship network of co-authors of Caifeng Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Caifeng Yue. A scholar is included among the top collaborators of Caifeng Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caifeng Yue. Caifeng Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wei, Wei, et al.. (2024). Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Prognostic Nutritional Index as Prognostic Markers for Lung Carcinoma. British Journal of Hospital Medicine. 85(10). 1–13. 5 indexed citations
3.
Zhang, Donghui, et al.. (2024). Construction and validation of a SASP‐related prognostic signature in patients with acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 28(16). e70017–e70017. 1 indexed citations
4.
Li, Ziyue, et al.. (2024). RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis. npj Precision Oncology. 8(1). 258–258.
5.
Yue, Caifeng, Chang Wang, Jiewei Chen, et al.. (2023). TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. 114(8). 3176–3189. 6 indexed citations
7.
Yu, Yang, et al.. (2023). Maximakinin reduced intracellular Ca2+ level in vascular smooth muscle cells through AMPK/ERK1/2 signaling pathways. Hypertension Research. 46(8). 1949–1960. 3 indexed citations
8.
Zhang, Donghui, Chong Zhang, Caifeng Yue, et al.. (2023). Recruitment of transcription factor ETS1 to activated accessible regions promotes the transcriptional program of cilia genes. Nucleic Acids Research. 51(13). 6684–6701. 3 indexed citations
9.
Yue, Caifeng, et al.. (2023). Tumor cell-derived exosomes mediating hsa_circ_0001739/lncRNA AC159540.1 facilitate liver metastasis in colorectal cancer. Cell Biology and Toxicology. 39(6). 2551–2568. 4 indexed citations
10.
Yue, Caifeng, et al.. (2023). Sequencing and analysis of micro RNAs in camel milk exosomes. Acta Veterinaria Hungarica. 71(2). 82–85. 4 indexed citations
11.
Chen, Jierong, Caifeng Yue, Dandan Zhu, et al.. (2022). HDAC8 Promotes Liver Metastasis of Colorectal Cancer via Inhibition of IRF1 and Upregulation of SUCNR1. Oxidative Medicine and Cellular Longevity. 2022(1). 2815187–2815187. 16 indexed citations
12.
Yue, Caifeng, et al.. (2021). sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2. Experimental Cell Research. 402(2). 112553–112553. 6 indexed citations
13.
Yue, Caifeng, et al.. (2020). microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis. Journal of Experimental & Clinical Cancer Research. 39(1). 240–240. 115 indexed citations
14.
Li, Laisheng, Jianbo Liang, Xiaoxia Zhan, et al.. (2019). Serum human epididymis protein 4 concentrations are associated with severity of patients with pulmonary tuberculosis. Clinica Chimica Acta. 502. 255–260. 8 indexed citations
15.
Yue, Caifeng, et al.. (2017). High serum uric acid concentration predicts poor survival in patients with breast cancer. Clinica Chimica Acta. 473. 160–165. 29 indexed citations
16.
Yuan, Linjing, Jianxin Wan, Chumei Huang, et al.. (2017). Evaluation of serum CCL18 as a potential biomarker for ovarian cancer. Cancer Biomarkers. 21(1). 97–104. 13 indexed citations
17.
Zheng, Fei-Meng, Caifeng Yue, Guohui Li, et al.. (2016). Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nature Communications. 7(1). 10180–10180. 146 indexed citations
18.
Wan, Jianxin, Yanhong Wang, Jianbo Liang, et al.. (2016). Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget. 7(42). 67748–67759. 43 indexed citations
19.
Yue, Caifeng, Duorong Xu, Jim S. Wu, et al.. (2016). Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies. Oncotarget. 7(33). 53930–53940. 8 indexed citations
20.
Zhou, Weihua, Caifeng Yue, Jie Xu, et al.. (2013). Autophagic Protein Beclin 1 Serves as an Independent Positive Prognostic Biomarker for Non-Small Cell Lung Cancer. PLoS ONE. 8(11). e80338–e80338. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026